Thus, in the above-described obesity models wherein hepatic activities of both Akt and aPKC are increased, both kinases may contribute to increases in hepatic lipogenesis and subsequent development of abdominal obesity, hepatosteatosis and hyperlipidemia. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.